Skip to main content

Computed Tomography/Magnetic Resonance Imaging of Adrenocortical Carcinoma

  • Chapter
  • First Online:
  • 636 Accesses

Abstract

This chapter describes the imaging features of adrenocortical carcinoma (ACC) and their use in detection, staging, and follow-up of the disease. The diagnostic imaging modalities most commonly used for this purpose are computed tomography (CT), magnetic resonance imaging (MRI), and FDG-positron emission tomography (PET).

Portions of this chapter have been described previously and are reproduced here with permission from Gross M, Korobkin M, Hussain HK et al (2010) Adrenal gland imaging. In: DeGroot LJ, Jameson JL (eds.) Endocrinology, 6th edn. Elsevier, Philadelphia, PA.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Francis IR et al (1992) Integrated imaging of adrenal disease. Radiology 182:1–13

    Google Scholar 

  2. Raisanen J et al (1984) Plasma catecholamines in pheochromocytoma: Effect of urographic contrast media. Am J Roentgenol 143:43–46

    CAS  Google Scholar 

  3. Mukherjee JJ et al (1997) Pheochromocytoma: Effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology 202:227–231

    PubMed  Google Scholar 

  4. Blake MA et al (2003) Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. Am J Roentgenol 181:1663–1668

    Google Scholar 

  5. Kloos RT et al (1995) Incidentally discovered adrenal masses. Endocr Rev 16:460–484

    CAS  PubMed  Google Scholar 

  6. Barzon L, Boscaro M (2000) Diagnosis and management of adrenal incidentalomas. J Urol 163:398–407

    Article  CAS  PubMed  Google Scholar 

  7. Bardet S et al (1996) 131I–6β–Iodomethylnorcholesterol scintigraphy: An assessment of its role in the investigation of adrenocortical incidentalomas. Clin Endocrinol 44:587–596

    Article  CAS  Google Scholar 

  8. Korobkin M et al (1996) The incidental adrenal mass. Radiol Clin North Am 34:1037–1054

    CAS  PubMed  Google Scholar 

  9. Gross MD, Shapiro B (1993) Clinically silent adrenal masses. J Clin Endocrinol Metab 77:885–888

    Article  CAS  PubMed  Google Scholar 

  10. Osella G et al (1994) Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J Clin Endocrinol Metab 79:1532–1539

    Article  CAS  PubMed  Google Scholar 

  11. Dunnick NR, Korobkin M (2002) Imaging of adrenal incidentalomas: Current status. Am J Roentgenol 179:559–568

    Google Scholar 

  12. Incidentally discovered adrenal mass (2002) National Institutes of Health (NIH) Consensus conference, Bethesda, MD, 4–6, February 2002

    Google Scholar 

  13. Cyran KM et al (1996) Adrenal myelolipoma. Am J Roentgenol 166:395–400

    CAS  Google Scholar 

  14. Rao P et al (1997) Imaging and pathologic features of myelolipoma. Radiographics 17:1373–1385

    CAS  PubMed  Google Scholar 

  15. Rozenblit A et al (1996) Cystic adrenal lesions: CT features. Radiology 201:541–548

    CAS  PubMed  Google Scholar 

  16. Xarli VP et al (1978) Adrenal hemorrhage in the adult. Medicine 57:211–221

    Article  CAS  PubMed  Google Scholar 

  17. Burks DW et al (1992) Acute adrenal injury after blunt abdominal trauma: CT findings. Am J Roentgenol 158:503–507

    CAS  Google Scholar 

  18. Ling D et al (1983) CT demonstration of bilateral adrenal hemorrhage. Am J Roentgenol 141:307–308

    CAS  Google Scholar 

  19. Roubidoux MA (1994) MR imaging of hemorrhage and iron deposition in the kidney. Radiographics 14:1033–1044

    CAS  PubMed  Google Scholar 

  20. Kawashima A et al (1999) Imaging of nontraumatic hemorrhage of the adrenal gland. Radiographics 19:949–963

    CAS  PubMed  Google Scholar 

  21. Commons RR, Callaway CP (1948) Adenomas of the adrenal cortex. Arch Intern Med 81:37–41

    CAS  Google Scholar 

  22. Kokko JP et al (1967) Adrenal adenoma and hypertension. Lancet 1:468–470

    Article  CAS  PubMed  Google Scholar 

  23. Hedeland H et al (1968) On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184:211–214

    Article  CAS  PubMed  Google Scholar 

  24. Russi S et al (1945) Small adenomas of the adrenal cortex in hypertension and diabetes. Arch Intern Med 76:284–291

    CAS  Google Scholar 

  25. Aso Y, Homma Y (1992) A survey on incidental adrenal tumors in Japan. J Urol 147:1478–1481

    CAS  PubMed  Google Scholar 

  26. Korobkin M FJ et al (1996) Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200:743–747

    CAS  PubMed  Google Scholar 

  27. Krestin GP et al (1991) Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT. J Comput Assist Tomogr 15:104–110

    Article  CAS  PubMed  Google Scholar 

  28. Dunnick NR et al (1996) Adrenal radiology: distinguishing benign from malignant adrenal masses. Am J Roentgenol 167:861–867

    CAS  Google Scholar 

  29. Korobkin M et al (1998) CT time-attenuation washout curves of adrenal adenomas and nonadenomas. Am J Roentgenol 170:747–752

    CAS  Google Scholar 

  30. Reinig JW et al (1986) Adrenal masses differentiated by MR. Radiology 158:81–84

    CAS  PubMed  Google Scholar 

  31. Outwater EK et al (1995) Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. Am J Roentgenol 165:579–583

    CAS  Google Scholar 

  32. Hedican SP, Marshall FF (1997) Adrenocortical carcinoma with intracaval extension. J Urol 158:2056–2061

    Article  CAS  PubMed  Google Scholar 

  33. Dunnick NR et al (1982) CT appearance of adrenal cortical carcinoma. J Comput Assist Tomogr 6:978–982

    Article  CAS  PubMed  Google Scholar 

  34. Fishman EK et al (1987) Primary adrenocortical carcinoma: CT evaluation with clinical correlation. Am J Roentgenol 148:531–535

    CAS  Google Scholar 

  35. Dunnick NR et al (1980) Intravenous extension of endocrine tumors. Am J Roentgenol 135:471–476

    CAS  Google Scholar 

  36. Lee MJ et al (1994) State-of-the-art MR imaging of the adrenal gland. Radiographics 14:1015–1029, 1994

    CAS  PubMed  Google Scholar 

  37. Schlund JF et al (1995) Adrenocortical carcinoma: MR imaging appearance with current techniques. J Magn Reson Imaging 5:171–174

    Article  CAS  PubMed  Google Scholar 

  38. Abrams HL et al (1950) Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 3:74–85

    Article  CAS  PubMed  Google Scholar 

  39. Zornoza J et al (1976) Radiologic features of adrensal metastases. Urology 8:295–299

    Article  CAS  PubMed  Google Scholar 

  40. Lee MJ et al (1991) Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179:415–418

    CAS  PubMed  Google Scholar 

  41. Korobkin M et al (1996) Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. Am J Roentgenol 166:531–536

    CAS  Google Scholar 

  42. Boland GW et al (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. Am J Roentgenol 171:201–204

    CAS  Google Scholar 

  43. Mitchell DG et al (1992) Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 185:345–351

    CAS  PubMed  Google Scholar 

  44. Israel GM et al (2004) Comparison of unenhanced CT and chemical shift MR imaging in evaluating lipid rich adrenal adenomas. Am J Roentgenol183:215–219

    Google Scholar 

  45. Outwater EK et al (1996) Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 200:749–752

    CAS  PubMed  Google Scholar 

  46. Haider MA et al (2004) Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 231:711–716

    Article  PubMed  Google Scholar 

  47. Szolar DH, Kammerhuber F (1997) Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? Radiology 202:517–521

    CAS  PubMed  Google Scholar 

  48. Krestin GP et al (1989) Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 171:675–680

    CAS  PubMed  Google Scholar 

  49. Szolar DH, Kammerhuber FH (1998) Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology 207:369–375

    CAS  PubMed  Google Scholar 

  50. Caoili EM et al (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. Am J Roentgenol 175:1411–1415

    CAS  Google Scholar 

  51. Peña CS et al (2000) Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217:798–802

    PubMed  Google Scholar 

  52. Caoili EM et al (2002) Combined unenhanced and delayed enhanced CT for characterization of adrenal masses. Radiology 222:629–633

    Article  PubMed  Google Scholar 

  53. Blake MA et al (2006) Distinguishing benig from maligant adrenal masses: multidetector row CT protocal with 10 minutes delay. Radiology 238: 578–585

    Article  PubMed  Google Scholar 

  54. Song JH et al (2007) The incidental indeterminate adrenal mass on CT (>10 HU) in patients without cancer. Is futher imaging necessary: follow up of 321 consecutive indeterminate adrenal masses. Am J Roentgenol 189:1119–1123

    Article  Google Scholar 

  55. Newhouse JH et al (1999) Large degenerated adrenal adenomas: radiologic-pathologic correlation. Radiology 210:385–391

    CAS  PubMed  Google Scholar 

  56. Szolar DH et al (2005) Adrenocortical carconomas and adrenal pheochromocytomas: Mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234:479–485

    Article  PubMed  Google Scholar 

  57. Slattery JM et al (2006) Adrenocortical carcinoma: contrast washout characteristics on CT. Am J. Roetgenol 187: W21–W24

    Google Scholar 

  58. Korobkin M, Francis IR (1997) Imaging of adrenal masses. Urol Clin North Am 24:603–622

    Article  CAS  PubMed  Google Scholar 

  59. Korobkin M, Francis IR (1995) Adrenal imaging. Semin Ultrasound CT MR 16:317–330

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Melvyn Korobkin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Korobkin, M., Avram, A.M., Hussain, H.K. (2009). Computed Tomography/Magnetic Resonance Imaging of Adrenocortical Carcinoma. In: Hammer, G., Else, T. (eds) Adrenocortical Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77236-3_6

Download citation

Publish with us

Policies and ethics